33.76
6.26%
1.99
시간 외 거래:
33.40
-0.36
-1.07%
전일 마감가:
$31.77
열려 있는:
$32.06
하루 거래량:
1.66M
Relative Volume:
0.98
시가총액:
$4.17B
수익:
$692.26M
순이익/손실:
$-512.41M
주가수익비율:
-7.9623
EPS:
-4.24
순현금흐름:
$-274.36M
1주 성능:
+10.91%
1개월 성능:
-5.65%
6개월 성능:
+18.83%
1년 성능:
+33.02%
가든트헬스 Stock (GH) Company Profile
명칭
Guardant Health Inc
전화
855-698-8887
주소
3100 HANOVER STREET, PALO ALTO
GH을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
33.76 | 4.17B | 692.26M | -512.41M | -274.36M | -4.24 |
TMO
Thermo Fisher Scientific Inc
|
532.02 | 203.50B | 42.37B | 6.14B | 7.78B | 15.95 |
DHR
Danaher Corp
|
234.84 | 169.62B | 23.74B | 3.89B | 4.98B | 5.24 |
A
Agilent Technologies Inc
|
135.69 | 38.75B | 6.51B | 1.29B | 1.37B | 4.42 |
IQV
Iqvia Holdings Inc
|
197.39 | 35.83B | 15.32B | 1.41B | 1.96B | 7.62 |
IDXX
Idexx Laboratories Inc
|
415.53 | 34.03B | 3.84B | 866.24M | 792.60M | 10.37 |
가든트헬스 Stock (GH) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-06-28 | 업그레이드 | Guggenheim | Neutral → Buy |
2024-06-03 | 재개 | Jefferies | Buy |
2024-04-24 | 재개 | Craig Hallum | Buy |
2023-12-14 | 개시 | Guggenheim | Neutral |
2023-12-13 | 개시 | Wolfe Research | Peer Perform |
2023-11-13 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
2023-09-28 | 개시 | Bernstein | Outperform |
2023-09-27 | 업그레이드 | Piper Sandler | Neutral → Overweight |
2023-07-05 | 재개 | JP Morgan | Overweight |
2023-05-26 | 업그레이드 | Citigroup | Neutral → Buy |
2023-05-05 | 개시 | UBS | Buy |
2023-03-09 | 다운그레이드 | Citigroup | Buy → Neutral |
2023-01-05 | 개시 | Scotiabank | Sector Outperform |
2022-11-01 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
2022-10-19 | 개시 | Craig Hallum | Buy |
2022-10-06 | 개시 | Stephens | Overweight |
2022-08-25 | 개시 | Credit Suisse | Outperform |
2022-06-03 | 개시 | Piper Sandler | Overweight |
2022-04-28 | 재개 | BTIG Research | Buy |
2022-02-24 | 재확인 | Canaccord Genuity | Buy |
2022-02-24 | 재확인 | Citigroup | Buy |
2022-02-24 | 재확인 | Cowen | Outperform |
2022-02-24 | 재확인 | Morgan Stanley | Overweight |
2022-02-24 | 재확인 | SVB Leerink | Outperform |
2022-02-24 | 재확인 | Stifel | Buy |
2022-02-24 | 재확인 | Wells Fargo | Overweight |
2021-10-15 | 재개 | Cowen | Outperform |
2021-06-15 | 개시 | Raymond James | Mkt Perform |
2021-06-03 | 개시 | Goldman | Buy |
2021-05-25 | 개시 | Wells Fargo | Overweight |
2021-01-11 | 개시 | Stifel | Buy |
2020-09-09 | 개시 | Morgan Stanley | Overweight |
2020-06-12 | 개시 | BTIG Research | Buy |
2020-02-21 | 개시 | Guggenheim | Buy |
2020-01-07 | 개시 | Citigroup | Buy |
2019-08-07 | 재확인 | Canaccord Genuity | Buy |
2019-04-16 | 개시 | Canaccord Genuity | Buy |
2019-04-10 | 업그레이드 | BofA/Merrill | Neutral → Buy |
2019-02-28 | 재확인 | BofA/Merrill | Neutral |
2018-10-29 | 개시 | BofA/Merrill | Neutral |
2018-10-29 | 개시 | JP Morgan | Overweight |
2018-10-29 | 개시 | William Blair | Outperform |
모두보기
가든트헬스 주식(GH)의 최신 뉴스
Piper Sandler maintains Overweight on Guardant Health stock By Investing.com - Investing.com UK
GHGuardant Health, Inc. Latest Stock News & Market Updates - StockTitan
Guardant Health to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - Business Wire
Guardant Health, Inc. (NASDAQ:GH) Sees Large Decline in Short Interest - MarketBeat
Why Guardant Health, Inc. (NASDAQ:GH) Could Be Worth Watching - Simply Wall St
Natera: Poised For A Great Future But I'd Wait For A Pullback (NASDAQ:NTRA) - Seeking Alpha
Sheffield United takeover completed by COH Sports - Reuters
FDA approves blood-based test screens for colon cancer - MSN
Geode Capital Management LLC Purchases 29,686 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health director Tariq Musa sells $4,042 in common stock - Investing.com India
Guardant Health Partners with MiBA to Transform Cancer Care with AI-Powered Precision Oncology - StockTitan
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Franklin Resources Inc. - MarketBeat
Guardant Health director Tariq Musa sells $4,042 in common stock By Investing.com - Investing.com South Africa
Meaningful Insights Biotech Analytics and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care - Marketscreener.com
Guardant Health and COTA partner in advanced oncology R&D - TipRanks
Guardant Health Partners with COTA to Revolutionize Cancer Drug Development Through AI-Powered Data - StockTitan
Y Intercept Hong Kong Ltd Sells 38,937 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health teams up with Boehringer for cancer test By Investing.com - Investing.com Australia
Guardant Health teams up with Boehringer for cancer test - Investing.com
Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer - Business Wire
Guardant Health Partners with Boehringer Ingelheim on Breakthrough Lung Cancer Diagnostic Test - StockTitan
Insider Selling: Guardant Health, Inc. (NASDAQ:GH) Director Sells 2,320 Shares of Stock - MarketBeat
Guardant Health director Tariq Musa sells $81,200 in stock - Investing.com
681,074 Shares in Guardant Health, Inc. (NASDAQ:GH) Bought by Lord Abbett & CO. LLC - MarketBeat
XTX Topco Ltd Has $409,000 Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Receives $40.60 Consensus Target Price from Analysts - MarketBeat
(GH) Trading Report - Stock Traders Daily
Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal - The Eastern Progress Online
Verition Fund Management LLC Buys 25,900 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium - The Bakersfield Californian
Wellington Management Group LLP Purchases 6,618,785 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health to Showcase Breakthrough Liquid Biopsy Research at Major Breast Cancer Symposium - StockTitan
Pier Capital LLC Buys 42,575 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Bought by Two Sigma Advisers LP - MarketBeat
Guardant Health, Inc. (NASDAQ:GH) Shares Sold by Polar Asset Management Partners Inc. - MarketBeat
Temasek Holdings Private Ltd Reduces Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Charles Schwab Investment Management Inc. Has $23.01 Million Stock Holdings in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Investors in Guardant Health (NASDAQ:GH) from three years ago are still down 61%, even after 8.6% gain this past week - Yahoo Finance
Strong week for Guardant Health (NASDAQ:GH) shareholders doesn't alleviate pain of three-year loss - Simply Wall St
Guardant Health stock soars to 52-week high of $37.04 By Investing.com - Investing.com Nigeria
Guardant Health Inc (GH) Shares Up 4.11% on Dec 4 - GuruFocus.com
Guardant Health stock soars to 52-week high of $37.04 - Investing.com
Guardant Health Stock Flashing Surefire ‘Buy’ Signal - Forbes
The Manufacturers Life Insurance Company Sells 28,746 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Guardant Health (FRA:5GH) Shares Outstanding (EOP) : 123.2 Mil (As of Sep. 2024) - GuruFocus.com
Liquid Biopsy Market Is Booming So Rapidly with Major Giants - openPR
Guardant awarded nearly $293M in false ad trial against Natera - MedTech Dive
Erste Asset Management GmbH Buys New Stake in Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
Fred Alger Management LLC Sells 43,039 Shares of Guardant Health, Inc. (NASDAQ:GH) - MarketBeat
GH (Guardant Health) EBITDA per Share : $-3.86 (TTM As of Sep. 2024) - GuruFocus.com
Guardant Health (STU:5GH) EPS (Diluted) : €-3.89 (TTM As of Sep. 2024) - GuruFocus.com
가든트헬스 (GH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
가든트헬스 주식 (GH) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
Kalia Kumud | Chief Information Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
2,690 |
0 |
21,098 |
Freeman Chris | Chief Commercial Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
3,595 |
0 |
35,852 |
EAGLE CRAIG | Chief Medical Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
3,381 |
0 |
27,343 |
Chudova Darya | Chief Technology Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
3,006 |
0 |
57,786 |
Bell Michael Brian | Chief Financial Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
2,084 |
0 |
27,772 |
Talasaz AmirAli | Co-Chief Executive Officer |
Dec 31 '24 |
Option Exercise |
0.00 |
11,462 |
0 |
2,215,894 |
Talasaz AmirAli | Co-Chief Executive Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
94,555 |
0 |
2,304,640 |
Eltoukhy Helmy | Co-Chief Executive Officer |
Dec 31 '24 |
Option Exercise |
0.00 |
11,462 |
0 |
2,315,728 |
Eltoukhy Helmy | Co-Chief Executive Officer |
Jan 01 '25 |
Option Exercise |
0.00 |
94,555 |
0 |
2,404,474 |
Krognes Steve E. | Director |
Dec 31 '24 |
Option Exercise |
0.00 |
155 |
0 |
10,220 |
자본화:
|
볼륨(24시간):